Syngene International Ltd.
| BSE: 539268 |
Sector: Health care |
| NSE: SYNGENE |
ISIN Code: INE398R01022 |
|
BSE
00:00 | 26 Feb
|
558.85
|
-3.45
(-0.61%)
|
OPEN
557.50
|
HIGH
562.00
|
LOW
553.55
|
|
NSE
00:00 | 26 Feb
|
559.15
|
-2.85
(-0.51%)
|
OPEN
564.95
|
HIGH
564.95
|
LOW
553.20
|
| OPEN |
557.50 |
| PREVIOUS CLOSE |
562.30 |
| VOLUME |
26260 |
| 52-Week high |
644.65 |
| 52-Week low |
201.65 |
| P/E |
61.55 |
| Mkt Cap.(Rs cr) |
22,354 |
| Buy Price |
558.00 |
| Buy Qty |
10.00 |
| Sell Price |
558.85 |
| Sell Qty |
25.00 |
| OPEN |
564.95 |
| PREVIOUS CLOSE |
562.00 |
| VOLUME |
307381 |
| 52-Week high |
644.55 |
| 52-Week low |
212.55 |
| P/E |
61.55 |
| Mkt Cap.(Rs cr) |
22,354 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
559.15 |
| Sell Qty |
75.00 |
| OPEN |
557.50 |
| CLOSE |
562.30 |
| VOLUME |
26260 |
| 52-Week high |
644.65 |
| 52-Week low |
201.65 |
| P/E |
61.55 |
| Mkt Cap.(Rs cr) |
22,354 |
| Buy Price |
558.00 |
| Buy Qty |
10.00 |
| Sell Price |
558.85 |
| Sell Qty |
25.00 |
| OPEN |
564.95 |
| PREVIOUS CLOSE |
562.00 |
| VOLUME |
307381 |
| 52-Week high |
644.55 |
| 52-Week low |
212.55 |
| P/E |
61.55 |
| Mkt Cap.(Rs cr) |
22354.00 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
559.15 |
| Sell Qty |
75.00 |
Syngene International Ltd. (SYNGENE) - Company Information
Syngene International Ltd
Syngene International Limited is an internationally reputed custom research and manufacturing organisation which supports R&D programs from lead generation to clinical supplies. The company was promoted by Biocon and Kiran Mazumdar Shaw a promoter of Biocon Limited. The company was formed with objectives of providing contract research service to overseas customer in the field of synthetic chemistr...> More
| COMPANY INFORMATION |
| Chairperson : |
Kiran Mazumdar Shaw |
| Non Executive Director : |
John Mccallum Marshall Shaw |
| Non Executive Director : |
Catherine Patricia Rosenberg |
| Independent Director : |
Bala S Manian |
| Independent Director : |
Paul Frederick Blackburn |
| Independent Director : |
Vijay Kuchroo |
| Managing Director & CEO : |
Jonathan Hunt |
| Independent Director : |
Vinita Bali |
| Company Secretary : |
Priyadarshnini Mahapatra |
| Independent Director : |
Sharmila Karve |
| Independent Director : |
Carl Decicco |
| AUDITOR : |
BSR & Co LLP |
| IND NAME : |
Pharmaceuticals - Indian - Bulk Drugs & Formln |
| HOUSE NAME : |
Indian Private |
| Registered office |
| Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds,Bengaluru,Karnataka-560099 |
| Ph : 91-80-68915000/67758781 |
| WEBSITE : http://www.syngeneintl.com |
| E-mail : investor@syngeneintl.com |
Quick Links for Syngene International:
